Skip to main content
Log in

The Pharmaceutical Year That Was, 2017

  • Editorial
  • Published:
Pharmaceutical Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fox AW. The pharmaceutical year that was, 2016. Pharm Med. 2016;30:317–9.

    Article  Google Scholar 

  2. Tovey A. Drug firms may face big damages bill from NHS for overcharging. Daily Telegraph 2016 Dec 8, Business, p 1.

  3. Towse A. The UK pharmaceutical market. An overview. Pharmacoeconomics. 1996;10(suppl 2):14–25.

    Article  PubMed  Google Scholar 

  4. Visco F. Fruitless drug research. NY Times. 2017;3:A20.

    Google Scholar 

  5. Slamon D, Eierman W, Robert N, et al. Adjuvant trastuzumab in HER-2 positive breast cancer. N Engl J Med. 2011;365:1273–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Lenzer J. Big data’s big bias: bringing noise and conflicts to US drug regulation. BMJ. 2017;358:j3275.

    Article  PubMed  Google Scholar 

  7. Deutsch K. Fentanyl outpaces heroin as the deadliest drug on Long Island. NY Times. 2016;29:A18–9.

    Google Scholar 

  8. McCarthy M. How inappropriate prescribing prompted the opioid addiction ravaging small town America. BMJ. 2017;359:j4730.

    Article  PubMed  Google Scholar 

  9. Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis. BMJ. 2017;359:j4792.

    Article  PubMed  Google Scholar 

  10. Bodkin H. Drug firms sue watchdog over price cap on medicines. Daily Telegr. 2017;11:6.

    Google Scholar 

  11. Withers I. Foreign drug giants behind challenge to NHS rationing. Daily Telegr. 2017;15:9.

    Google Scholar 

  12. European Medicines Agency. EMA working group on committees’ operational preparedness for human medicines. EMA/300951/2017. London: EMA; 2017.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anthony W. Fox.

Ethics declarations

Funding

No funding was provided for the publication of this work.

Conflict of interest

Tony Fox declares that he holds no stock in any company that is marketing pharmaceutical products, and he has had no emoluments, of any type, from such a company during at least the past 5 years.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fox, A.W. The Pharmaceutical Year That Was, 2017. Pharm Med 31, 379–382 (2017). https://doi.org/10.1007/s40290-017-0214-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40290-017-0214-6

Navigation